Moderna Covid Shots Turned Down by Buyers on Delivery Woes (2)

April 5, 2022, 4:38 PM UTC

Two buyers of Covid-19 vaccines for low- and middle-income countries have declined options to purchase hundreds of millions of additional doses from Moderna Inc., a sign of waning demand as the pandemic eases.

The African Union and Covax, the World Health Organization-backed group, decided not to obtain more of the vaccine as developing nations struggle to turn supplies into inoculations. Lower-income countries left behind in the global rollout are now grappling with a lack of funds, hesitancy, supply-chain obstacles and other factors that are hampering distribution.

For months, Moderna’s highly effective messenger RNA vaccine was out of reach ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.